欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	DK/H/1950/002
药品名称	Sevelamercarbonat "Aurobindo"
活性成分	sevelamer carbonate 2.4 g
剂型	Powder for oral suspension
上市许可持有人	Aurobindo Pharma (Malta) Limited Vault 14, Level 2 FRN 1913 Valletta Waterfront, Floriana Malta
参考成员国 - 产品名称	Denmark (DK) Sevelamercarbonat "Aurobindo"
互认成员国 - 产品名称	Italy (IT)
许可日期	2017/06/02
最近更新日期	2023/04/26
药物ATC编码	V03AE02 sevelamer
申请类型	TypeLevel1：Known Active Substance TypeLevel2：Initial Application TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC TypeLevel4：Chemical Substance TypeLevel5：Prescription Only
附件文件下载	Final PL \| 1950 common-pl-cleanDate of last change:2020/11/06 Final SPC \| 1950 common-spc-cleanDate of last change:2020/11/06 Final Product Information \| common-pl-2decimal4gDate of last change:2019/11/11 Final Product Information \| common-spc-800mgDate of last change:2019/11/11 Final Product Information \| common-spc-2decimal4gDate of last change:2019/11/11 Final Product Information \| common-pl-800mgDate of last change:2019/11/11 PAR Summary \| Summary Public Assessment Report_DK_H_1950_002_DCDate of last change:2017/07/31 PAR \| Module 5 public summary and scientific discussion_DK_H_1950_002_DCDate of last change:2017/07/31 Final Labelling \| common-LABDate of last change:2017/06/02
市场状态	Positive